LakeShore Biopharma Co., Ltd. Quarterly Stockholders' Equity Attributable to Parent in CNY from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: CNY and USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
LakeShore Biopharma Co., Ltd. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q1 2020 to Q1 2024.
  • LakeShore Biopharma Co., Ltd. Stockholders' Equity Attributable to Parent for the quarter ending March 31, 2024 was ¥585M, a 19.7% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (CNY)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 585M -143M -19.7% Mar 31, 2024 20-F 2024-08-15
Q1 2023 728M +1.43B Mar 31, 2023 20-F 2024-08-15
Q1 2022 -699M -190M -37.4% Mar 31, 2022 20-F 2024-08-15
Q1 2021 -509M +338M +39.9% Mar 31, 2021 20-F 2024-08-15
Q1 2020 -847M Mar 31, 2020 20-F 2023-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.